BARX Homeobox 2 抗体 (AA 31-80)
Our Local Distributor
北京 101111
Quick Overview for BARX Homeobox 2 抗体 (AA 31-80) (ABIN6744580)
抗原
See all BARX Homeobox 2 (BARX2) 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 31-80
-
特异性
- Mouse BARX2
-
预测反应
- Percent identity by BLAST analysis: Human, Mouse, Rat, Dog, Bovine, Rabbit, Guinea pig, Chicken (92%).
-
纯化方法
- Immunoaffinity purified
-
免疫原
-
Synthetic peptide located between aa31-80 of mouse Barx2 (O08686, NP_038828). Percent identity by BLAST analysis: Human, Chimpanzee, Mouse, Rat (100%), Gorilla, Gibbon, Monkey, Galago, Marmoset, Hamster, Elephant, Panda, Dog, Bovine, Bat, Rabbit, Horse, Pig, Opossum, Guinea pig, Turkey, Chicken, Stickleback (92%).
Type of Immunogen: Synthetic peptide
-
-
anti-BARX Homeobox 2 (BARX2) (AA 161-260) antibody
BARX2 适用: 人 WB, ELISA 宿主: 小鼠 Monoclonal 2B8 unconjugated
anti-BARX Homeobox 2 (BARX2) antibodyMicroarray verified BARX2 适用: 人 IHC 宿主: 小鼠 Monoclonal MAB856227 unconjugated
anti-BARX Homeobox 2 (BARX2) (AA 161-260) antibodyBARX2 适用: 人 WB, ELISA 宿主: 小鼠 Monoclonal 2B8 unconjugated
anti-BARX Homeobox 2 (BARX2) (AA 65-114) antibodyBARX2 适用: 人, 马, 兔, 豚鼠, Bat WB 宿主: 兔 Polyclonal unconjugated
anti-BARX Homeobox 2 (BARX2) (N-Term) antibodyBARX2 适用: 大鼠, 小鼠, 人, 马, 兔, Cow, Bat, Hamster, Pig WB 宿主: 兔 Polyclonal unconjugated
anti-BARX Homeobox 2 (BARX2) (N-Term) antibodyBARX2 适用: 大鼠, 人, 犬, 马, 兔, 豚鼠, Cow WB 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
-
Approved: WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody. -
说明
-
Target Species of Antibody: Mouse
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Distilled water
-
浓度
- Lot specific
-
缓冲液
- Lyophilized from PBS with 2 % sucrose
-
注意事项
- Avoid repeat freeze-thaw cycles.
-
储存条件
- 4 °C,-20 °C
-
储存方法
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
-
